Immunotherapy with or without targeted therapy for metastatic upper tract urothelial carcinoma: case report and literature review.

Heliyon(2023)

Cited 0|Views12
No score
Abstract
For patients who are ineligible for chemotherapy, immunotherapy might be a feasible treatment, regardless of whether or not they are given VEGFR2 inhibitors.
More
Translated text
Key words
urothelial carcinoma,metastatic upper tract,targeted immunotherapy
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined